Connection

BENNY KAIPPARETTU to Humans

This is a "connection" page, showing publications BENNY KAIPPARETTU has written about Humans.
Connection Strength

0.346
  1. G-protein coupled receptors in metabolic reprogramming and cancer. Pharmacol Ther. 2025 Jun; 270:108849.
    View in: PubMed
    Score: 0.026
  2. Biguanides antithetically regulate tumor properties by the dose-dependent mitochondrial reprogramming-driven c-Src pathway. Cell Rep Med. 2025 Feb 18; 6(2):101941.
    View in: PubMed
    Score: 0.026
  3. CD24 negativity reprograms mitochondrial metabolism to PPARa and NF-?B-driven fatty acid ?-oxidation in triple-negative breast cancer. Cancer Lett. 2024 Apr 10; 587:216724.
    View in: PubMed
    Score: 0.024
  4. Metabolomic Rewiring Promotes Endocrine Therapy Resistance in Breast Cancer. Cancer Res. 2024 01 16; 84(2):291-304.
    View in: PubMed
    Score: 0.024
  5. Fatty Acid Oxidation-Driven Src Links Mitochondrial Energy Reprogramming and Oncogenic Properties in Triple-Negative Breast Cancer. Cell Rep. 2016 Mar 08; 14(9):2154-2165.
    View in: PubMed
    Score: 0.014
  6. Crosstalk from non-cancerous mitochondria can inhibit tumor properties of metastatic cells by suppressing oncogenic pathways. PLoS One. 2013; 8(5):e61747.
    View in: PubMed
    Score: 0.012
  7. Transmitochondrial cybrids: tools for functional studies of mutant mitochondria. Methods Mol Biol. 2012; 837:219-30.
    View in: PubMed
    Score: 0.011
  8. Functional effects of cancer mitochondria on energy metabolism and tumorigenesis: utility of transmitochondrial cybrids. Ann N Y Acad Sci. 2010 Jul; 1201:137-46.
    View in: PubMed
    Score: 0.009
  9. Novel egg white-based 3-D cell culture system. Biotechniques. 2008 Aug; 45(2):165-8, 170-1.
    View in: PubMed
    Score: 0.008
  10. Estrogen-mediated downregulation of CD24 in breast cancer cells. Int J Cancer. 2008 Jul 01; 123(1):66-72.
    View in: PubMed
    Score: 0.008
  11. Computational modeling of cancer cell metabolism along the catabolic-anabolic axes. NPJ Syst Biol Appl. 2025 May 10; 11(1):46.
    View in: PubMed
    Score: 0.007
  12. IDH status dictates oHSV mediated metabolic reprogramming affecting anti-tumor immunity. Nat Commun. 2025 Apr 24; 16(1):3874.
    View in: PubMed
    Score: 0.007
  13. Testosterone Modulation of Muscle Transcriptomic Profile During Lifestyle Therapy in Older Men with Obesity and Hypogonadism. J Cachexia Sarcopenia Muscle. 2025 Feb; 16(1):e13697.
    View in: PubMed
    Score: 0.007
  14. Mitochondrial reprogramming by activating OXPHOS via glutamine metabolism in African American patients with bladder cancer. JCI Insight. 2024 Sep 10; 9(17).
    View in: PubMed
    Score: 0.006
  15. EpCAM-targeted betulinic acid analogue nanotherapy improves therapeutic efficacy and induces anti-tumorigenic immune response in colorectal cancer tumor microenvironment. J Biomed Sci. 2024 Aug 20; 31(1):81.
    View in: PubMed
    Score: 0.006
  16. Glutathione S-transferase M1 and T1 null genotype distribution in South Indians. Eur J Clin Pharmacol. 2004 Aug; 60(6):403-6.
    View in: PubMed
    Score: 0.006
  17. Interplay of gut microbiota and host epithelial mitochondrial dysfunction is necessary for the development of spontaneous intestinal inflammation in mice. Microbiome. 2023 11 17; 11(1):256.
    View in: PubMed
    Score: 0.006
  18. A defect in mitochondrial fatty acid synthesis impairs iron metabolism and causes elevated ceramide levels. Nat Metab. 2023 09; 5(9):1595-1614.
    View in: PubMed
    Score: 0.006
  19. Targeting aberrant replication and DNA repair events for treating breast cancers. Commun Biol. 2022 05 24; 5(1):493.
    View in: PubMed
    Score: 0.005
  20. A mechanistic modeling framework reveals the key principles underlying tumor metabolism. PLoS Comput Biol. 2022 02; 18(2):e1009841.
    View in: PubMed
    Score: 0.005
  21. Patient-derived iPSCs link elevated mitochondrial respiratory complex I function to osteosarcoma in Rothmund-Thomson syndrome. PLoS Genet. 2021 12; 17(12):e1009971.
    View in: PubMed
    Score: 0.005
  22. Targeting Mitochondrial Damage as a Therapeutic for Ileal Crohn's Disease. Cells. 2021 05 29; 10(6).
    View in: PubMed
    Score: 0.005
  23. Towards decoding the coupled decision-making of metabolism and epithelial-to-mesenchymal transition in cancer. Br J Cancer. 2021 06; 124(12):1902-1911.
    View in: PubMed
    Score: 0.005
  24. Ataxia-telangiectasia mutated interacts with Parkin and induces mitophagy independent of kinase activity. Evidence from mantle cell lymphoma. Haematologica. 2021 02 01; 106(2):495-512.
    View in: PubMed
    Score: 0.005
  25. Genetic polymorphism of CYP2D6 in Karnataka and Andhra Pradesh population in India. Acta Pharmacol Sin. 2000 Jun; 21(6):494-8.
    View in: PubMed
    Score: 0.005
  26. TP53 Status as a Determinant of Pro- vs Anti-Tumorigenic Effects of Estrogen Receptor-Beta in Breast Cancer. J Natl Cancer Inst. 2019 11 01; 111(11):1202-1215.
    View in: PubMed
    Score: 0.005
  27. Therapeutic inhibition of mTORC2 rescues the behavioral and neurophysiological abnormalities associated with Pten-deficiency. Nat Med. 2019 11; 25(11):1684-1690.
    View in: PubMed
    Score: 0.005
  28. Aerobic Plus Resistance Exercise in Obese Older Adults Improves Muscle Protein Synthesis and Preserves Myocellular Quality Despite Weight Loss. Cell Metab. 2019 08 06; 30(2):261-273.e6.
    View in: PubMed
    Score: 0.004
  29. Assessing Therapeutic Efficacy in Real-time by Hyperpolarized Magnetic Resonance Metabolic Imaging. Cells. 2019 04 11; 8(4).
    View in: PubMed
    Score: 0.004
  30. Elucidating cancer metabolic plasticity by coupling gene regulation with metabolic pathways. Proc Natl Acad Sci U S A. 2019 02 26; 116(9):3909-3918.
    View in: PubMed
    Score: 0.004
  31. Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer. J Clin Invest. 2018 04 02; 128(4):1283-1299.
    View in: PubMed
    Score: 0.004
  32. GLUT12 promotes prostate cancer cell growth and is regulated by androgens and CaMKK2 signaling. Endocr Relat Cancer. 2018 04; 25(4):453-469.
    View in: PubMed
    Score: 0.004
  33. Tobacco-Specific Carcinogens Induce Hypermethylation, DNA Adducts, and DNA Damage in Bladder Cancer. Cancer Prev Res (Phila). 2017 Oct; 10(10):588-597.
    View in: PubMed
    Score: 0.004
  34. B-cell Receptor Signaling Regulates Metabolism in Chronic Lymphocytic Leukemia. Mol Cancer Res. 2017 12; 15(12):1692-1703.
    View in: PubMed
    Score: 0.004
  35. Polymorphism of the DNA repair enzyme XRCC1 is associated with treatment prediction in anthracycline and cyclophosphamide/methotrexate/5-fluorouracil-based chemotherapy of patients with primary invasive breast cancer. Pharmacogenet Genomics. 2007 Jul; 17(7):529-38.
    View in: PubMed
    Score: 0.004
  36. Modeling the Genetic Regulation of Cancer Metabolism: Interplay between Glycolysis and Oxidative Phosphorylation. Cancer Res. 2017 04 01; 77(7):1564-1574.
    View in: PubMed
    Score: 0.004
  37. Bifunctional Luminomagnetic Rare-Earth Nanorods for High-Contrast Bioimaging Nanoprobes. Sci Rep. 2016 09 02; 6:32401.
    View in: PubMed
    Score: 0.004
  38. Inhibition of the hexosamine biosynthetic pathway promotes castration-resistant prostate cancer. Nat Commun. 2016 05 19; 7:11612.
    View in: PubMed
    Score: 0.004
  39. The autophagy inhibitor chloroquine targets cancer stem cells in triple negative breast cancer by inducing mitochondrial damage and impairing DNA break repair. Cancer Lett. 2016 07 01; 376(2):249-58.
    View in: PubMed
    Score: 0.004
  40. Multilevel Genomics-Based Taxonomy of Renal Cell Carcinoma. Cell Rep. 2016 Mar 15; 14(10):2476-89.
    View in: PubMed
    Score: 0.004
  41. Probing highly luminescent europium-doped lanthanum orthophosphate nanorods for strategic applications. Inorg Chem. 2015 Mar 16; 54(6):2616-25.
    View in: PubMed
    Score: 0.003
  42. MALDI-TOF MS and TaqMan assisted SNP genotyping of DNA isolated from formalin-fixed and paraffin-embedded tissues (FFPET). Hum Mutat. 2005 Mar; 25(3):232-8.
    View in: PubMed
    Score: 0.003
  43. CYP2C9 and CYP2C19 genetic polymorphisms: frequencies in the south Indian population. Fundam Clin Pharmacol. 2005 Feb; 19(1):101-5.
    View in: PubMed
    Score: 0.003
  44. Prevalence of CD44+/CD24-/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis. Clin Cancer Res. 2005 Feb 01; 11(3):1154-9.
    View in: PubMed
    Score: 0.003
  45. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell. 2014 Sep 08; 26(3):319-330.
    View in: PubMed
    Score: 0.003
  46. Highly luminescent-paramagnetic nanophosphor probes for in vitro high-contrast imaging of human breast cancer cells. Small. 2012 Oct 08; 8(19):3028-34.
    View in: PubMed
    Score: 0.003
  47. Hybrid 2D nanomaterials as dual-mode contrast agents in cellular imaging. Adv Mater. 2012 Jun 12; 24(22):2992-8.
    View in: PubMed
    Score: 0.003
  48. Graphene quantum dots derived from carbon fibers. Nano Lett. 2012 Feb 08; 12(2):844-9.
    View in: PubMed
    Score: 0.003
  49. Mitochondria of highly metastatic breast cancer cell line MDA-MB-231 exhibits increased autophagic properties. Biochim Biophys Acta. 2011 Sep; 1807(9):1125-32.
    View in: PubMed
    Score: 0.003
  50. Mechanisms of estrogen receptor antagonism toward p53 and its implications in breast cancer therapeutic response and stem cell regulation. Proc Natl Acad Sci U S A. 2010 Aug 24; 107(34):15081-6.
    View in: PubMed
    Score: 0.002
  51. Genetic polymorphism of CYP2D6 in a keralite (South India) population. Br J Clin Pharmacol. 2000 Mar; 49(3):285-6.
    View in: PubMed
    Score: 0.002
  52. SAFB1 mediates repression of immune regulators and apoptotic genes in breast cancer cells. J Biol Chem. 2010 Feb 05; 285(6):3608-3616.
    View in: PubMed
    Score: 0.002
  53. Investigation of genetic variants of genes of the hemochromatosis pathway and their role in breast cancer. Cancer Epidemiol Biomarkers Prev. 2005 May; 14(5):1102-7.
    View in: PubMed
    Score: 0.002
  54. Genetic polymorphism of CYP2D6 in Tamil population. Eur J Clin Pharmacol. 2001 Jan-Feb; 56(11):849-50.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.